Companies: 10,795·Total market cap: $144.5T
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

GZPHFOTCHealthcare● Active
$2.34
+$0.00(+0.00%)
Market Cap$6.2B
P/E Ratio—
52W High$2.88
52W Low$2.14
Overview
Stock ranking:Drug Manufacturers - Specialty & Generic·Healthcare·View All Market Cap Rankings →

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · GZPHF · as of Jun 9, 2026

Key Statistics

EPS (TTM)$1.82gzphf eps ttm · gzphf earnings per shareEarnings history
PE Ratio (TTM)1.3×gzphf pe ratio ttm · gzphf price to earningsPE Ratio deep dive
Revenue (TTM)$78.0Bgzphf revenue ttm · gzphf annual revenueFull revenue history
Dividend Yield4.94%does gzphf pay dividends · gzphf dividend yieldDividend history
Shares Outstanding1.63Bgzphf shares outstanding · gzphf floatShares outstanding history
Next EarningsAug 14, 2026Est.gzphf earnings date · gzphf next earningsEarnings history

Explore Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Data

gzphf stock data · financials
Market Cap$6.2Bgzphf market cap · gzphf valuation
Analyst Forecast—
Dividends4.94%does guangzhou baiyunshan pharmaceutical holdings company limited pay dividends · gzphf dividend yield
Revenue$75.4B+0.61%guangzhou baiyunshan pharmaceutical holdings company limited annual revenue · gzphf revenue
EarningsEPS $1.82+4.60%gzphf earnings · gzphf eps
PE Ratio1.3×gzphf pe ratio · gzphf price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$75.45B▲ +0.61% YoY
202320242025
guangzhou baiyunshan pharmaceutical holdings company limited revenue · gzphf revenue 2025
FY 2025Net Income$2.91B▲ +2.49% YoY
202320242025
guangzhou baiyunshan pharmaceutical holdings company limited net income · gzphf profit 2025
FY 2025EPS$1.82▲ +4.60% YoY
202320242025
gzphf eps · guangzhou baiyunshan pharmaceutical holdings company limited earnings per share 2025
TTM:Revenue: $77.99BNet Income: $2.93BEPS: $1.82View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+9.35%
1Y+6.36%
5Y-16.43%

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

CEOHong Li
IPO DateJan 5, 2010
Employees28,138
CountryCN
Websitegybys.com.cn

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF), operating with its various subsidiaries, is a diversified pharmaceutical conglomerate primarily engaged in the research, developme…

Drug Manufacturers - Specialty & GenericHealthcareOTCCN

what is guangzhou baiyunshan pharmaceutical holdings company limited · gzphf stock overview · guangzhou baiyunshan pharmaceutical holdings company limited company profile · who is guangzhou baiyunshan pharmaceutical holdings company limited ceo · gzphf OTC · guangzhou baiyunshan pharmaceutical holdings company limited headquarters · guangzhou baiyunshan pharmaceutical holdings company limited business segments

About Stock Overview & Key Data

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jan 5, 2010. As of the latest trading session, GZPHF stock price is $2.34, with a market capitalization of $6.2B. The stock has returned +6.36% over the past 12 months and +9.35% year-to-date.

In fiscal year 2025, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited reported revenue of $75.4B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GZPHF) stock price is $2.34. The stock is traded on OTC under the ticker symbol GZPHF. The 52-week range is $2.14 – $2.88.

GZPHF stock priceGZPHF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice